Skip to content

TMD CONSULTING

Active
Private limited companyfounded 20224 yrs activeKolomstraat 1A, 1080 Sint-Jans-Molenbeek, BelgiumKBO/BCE: BE 0779.754.294

The computed 12-month bankruptcy probability of TMD CONSULTING is 4.7% (elevated). The 2023 annual accounts show equity of €117k and a net result of €10k. The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

No current score
Figures too old
The available figures for FY 2023 are too old to assess current financial health.
Bankruptcy probability: Elevated
Axes, FY 2023 · tick = 2022
Profitability75▼-25
Solvency87▲+7
Growth52
Track record94
Bankruptcy probability, 12 months
4.7% Elevated
0%0.5%1.5%4%10%≥ 25%
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 4 years 0 10 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2023
Solvency, return and age of the figures
Solvency
62%
Return on assets
5.1%
Age of the figures
33 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-08-2026, 19 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 4 filings
Deviation from the deadline
2025
19 d late
2024
382 d late
2023
66 d late
2022
124 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2023, micro schema

Equity
€117k▲ 9.0%
2022 · €107k
2022: €107k
2022 → 2023
Total assets
€188k▼ 2.6%
2022 · €193k
2022: €193k
2022 → 2023
Net result
€10k▼ 90.8%
2022 · €103k
2022: €103k
2022 → 2023
Working capital
€119k▼ 3.7%
2022 · €123k
2022: €123k
2022 → 2023
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20222023Trend
Equity€107k-€117k▲ 9.0%
Operating result€187k-€16k▼ 91.5%
Net result€103k-€10k▼ 90.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150k€200kOperating result 2022: €187k€187kNet result 2022: €103k€103kOperating result 2023: €16k€16kNet result 2023: €10k€10k20222023
The operating result falls in 2023; 2023 is 92% below 2022.
Balance-sheet composition
2023 in colour, 2022 as the grey bar beneath
Assets €188k
Fixed assets €15k▲ 44.0%
Current assets €173k▼ 5.4%
Equity and liabilities €188k
Equity €117k▲ 9.0%
Debt €72k▼ 17.1%
The debt ratio falls from 44.6% to 38.0%. Equity is higher and debt is lower.
Key figures and ratios
2023 value · change against 2022
EBITDA
€19k
2022 · €190k
Cash flow
€13k
2022 · €105k
Solvency
62.0%
2022 · 55.4%
Current ratio
3.21
2022 · 3.09
Quick ratio
3.21
2022 · 3.09
Debt / equity
0.61
2022 · 0.81
ROE
8.2%
2022 · 96.3%
ROA
5.1%
2022 · 53.3%
Interest coverage
10.81
2022 · 72.68
Debt
€72k
2022 · €86k
Debt ≤ 1 year
€54k
2022 · €59k
Debt > 1 year
€18k
2022 · €27k
Income taxes
€5k
2022 · €30k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2023 against 2022
Balance sheet Code20222023
Assets
Total assets20/58€193k€188k
Fixed assets21/28€11k€15k
Tangible fixed assets22/27€9k€14k
Plant, machinery and equipment23-€3k
Furniture and vehicles24€7k€6k
Other tangible fixed assets26€2k€4k
Financial fixed assets28€2k€2k=
Current assets29/58€183k€173k
Amounts receivable within one year40/41€114k€119k
Trade receivables40€49k€21k
Other amounts receivable41€65k€99k
Cash at bank and in hand54/58€20k€7k
Deferred charges and accrued income490/1€49k€47k
Equity and liabilities
Total equity and liabilities10/49€193k€188k
Equity10/15€107k€117k
Contributions10/11€4k€4k=
Profit (loss) carried forward14€103k€113k
Amounts payable17/49€86k€72k
Amounts payable after more than one year17€27k€18k
Financial debts170/4€27k€18k
Amounts payable within one year42/48€59k€54k
Current portion of amounts payable after more than one year42€19k€9k
Trade debts44€20k€4k
Suppliers440/4€20k€4k
Advances received on contracts in progress46-€13k
Taxes, remuneration and social security45€18k€5k
Taxes450/3€18k€5k
Other amounts payable47/48€2k€23k
Income statement Code20222023
Non-recurring operating income76A€46k€9k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€3k
Other operating charges640/8€4k€2k
Gross operating margin9900€193k€21k
Operating profit (loss)9901€187k€16k
Financial income75/76B€1€59
Recurring financial income75€1€59
Financial charges65/66B€54k€2k
Recurring financial charges65€3k€2k
Non-recurring financial charges66B€51k-
Profit (loss) for the period before taxes9903€134k€14k
Income taxes67/77€30k€5k
Profit (loss) for the period9904€103k€10k
Profit (loss) for the period to be appropriated9905€103k€10k
Appropriation of the result
Profit (loss) to be appropriated9906€103k€113k
Profit (loss) brought forward from the previous period14P-€103k

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
19-08
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema · 19 days late
17-08
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema · 382 days late
2024
05-10
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 66 days late
2023
29-03
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
NBB filing

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Jans-Molenbeek · 1 establishment unit since 2022
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Kolomstraat 1A1080 Sint-Jans-Molenbeek
Ground area
3,297 m²
Building footprint
556 m²
Volume, LiDAR
4,158 m³
2 parcels, Brussels, Wallonia · tallest building 19.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
TMD Pharma
Rue Marlagne 41, 6470 Sivry-RanceBusiness consulting
since 20222.326.785.322
2 parcels
Wallonia 1 (50%) Brussels 1 (50%)
Parcel (capakey) Region Area Buildings Height / fl.
21522B0623/00L000 Brussels 2,442 m² 1 · 406 m² 19.8 m · 2 fl.
56061C0346/00D000 Wallonia 854 m² 1 · 149 m² 6.3 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,487 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded05-01-2022
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
70200Business and other management consultancy
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers

Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.

Contact details

1 entry
E-mail:info@tmdconsulting.be
Establishment Sivry-Rance 2.326.785.322